Catalyst Funds Management Pty Ltd

Position in DGX — Quest Diagnostics Inc

CIK 1896150 SYDNEY NSW, C3

Position in DGX

as of Mar 31, 2026 · filed May 11, 2026 Compact

Position Value

$208,718

+$146,618 QoQ

Shares Held

1,065

+166.2% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2024

4 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Catalyst Funds Management Pty Ltd holds $1,479,733 across 6 Diagnostics & Research names. DGX ranks #4 (14.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MEDP	Medpace Holdings, Inc.	1,040	$499,397
2	VCYT	Veracyte, Inc.	8,700	$280,227
3	WAT	Waters Corp /De/	920	$273,976
4	DGX	Quest Diagnostics Inc This page	1,065	$208,718
5	MYGN	Myriad Genetics Inc	33,980	$152,910
6	MDXH	MDxHealth SA	28,046	$64,505

4 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$208,718	1,065	+166.2%	Shares	Sole	2026-05-11
2024-09-30	$62,100	400	-55.6%	Shares	Sole	2024-11-14
2024-06-30	$123,192	900	+350.0%	Shares	Sole	2024-12-18
2024-03-31	$26,622	200	—	Shares	Sole	2024-12-05
No filing history on record for this holder in this stock.